Mitch Test
The COVID-19 pandemic showed how poorly prepared we were to deal with a newly-emerging respiratory virus. Antiviral drugs with the appropriate spectrum of activity can protect against a new pandemic threat until a vaccine can be developed and deployed. Drugs should be suitable for post-exposure prophylaxis or treatment of mild disease, possess oral activity with a good safety profile, have low cost of goods, and be easy to deliver and suitable for combination. The global research community must act collectively to generate a toolkit of antiviral agents covering a number of viral families. Scientists from many sectors – industry, academia, non-profits – will be involved, working in a multidisciplinary effort. This presentation provides a perspective on pandemic preparedness, the approaches that are being taken to tackle this problem, and the need to ensure equitable access to any drugs that are developed.
When:
Friday, January 6, 2023, 12:00 PM - Saturday, January 7, 2023, 12:00 AM ET
Where:
Location: Virtual
- On the day of the event, visit the My Dashboard page to attend virtually.
Questions or concerns?
Please contact aferreras@nas.edu.